Skip to content
OpenCapital
Get started

Boston Scientific BSX Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B0.0%
TFX
TeleflexTFX
44.3M-3.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Stryker logo
StrykerSYK
386.5M0.0%
Haemonetics logo
HaemoneticsHAE
47.4M-6.7%
CONMED logo
CONMEDCNMD
30.6M-1.7%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$65.7B-56.2%
P/E18.5×-55.6×
P/S3.2×-5.4×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's shares (diluted)?
Boston Scientific (BSX) reported shares (diluted) of 1.5B in Q1 2026.
How has Boston Scientific's shares (diluted) changed year-over-year?
Boston Scientific's shares (diluted) increased by 0.1% year-over-year, from 1.5B to 1.5B.
What is the long-term trend for Boston Scientific's shares (diluted)?
Over 4 years (2021 to 2025), Boston Scientific's shares (diluted) has grown at a 1.0% compound annual growth rate (CAGR), from 5.7B to 6B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.